MedPath

Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module

Terminated
Conditions
Normal Eyes
Retinal Vascular
Interventions
Device: OCT Angiography
Device: Color Fundus Photography
Device: Optical Coherence Tomography
Registration Number
NCT03530449
Lead Sponsor
Heidelberg Engineering GmbH
Brief Summary

Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS

Detailed Description

The objectives of this study are to:

1. Assess the repeatability and reproducibility of the SPECTRALIS with OCTA Module image quality

2. Assess the repeatability and reproducibility of visibility of key anatomical vascular structures in the SPECTRALIS with OCTA Module

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • All subjects: Able and willing to undergo the test procedures, sign informed consent, and follow instructions.
  • Age ≥ 22

Subjects with Normal Eyes:

  • Corrected visual acuity ≥ 20/40 in each eye

Subjects with Pathology:

  • Subjects with vascular retinal conditions in at least one eye
  • Subjects included should have a range of retinal vascular pathologies likely to appear in OCTA imaging, affecting different anatomic depths through the retina and choroid. Retinal conditions including but not limited to diabetic retinopathy, wet age-related macular degeneration (AMD), and branch or central retinal vein occlusion that give rise to features such as retinal ischemia, microaneurysms, choroidal neovascularization and retinal neovascularization will be included.
Exclusion Criteria
  • All Subjects:
  • Subjects unable to read or write
  • Subjects with ocular media not sufficiently clear to obtain acceptable study- related imaging
  • Subjects who cannot tolerate the imaging procedures
  • Subjects with contraindication to pupillary dilation in the study eye
  • Subjects with Normal Eyes:
  • Subjects with uncontrolled systemic conditions, or ocular disease, as determined by the Investigator, during the eye exam and CFP
  • History of ocular surgical intervention (except for refractive or cataract surgery) in either eye

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Subjects with Normal EyesOCT AngiographyColor Fundus Photography, Optical Coherence Tomography, and OCT Angiography scans as per protocol in subjects without ophthalmic pathology
Subjects with Normal EyesOptical Coherence TomographyColor Fundus Photography, Optical Coherence Tomography, and OCT Angiography scans as per protocol in subjects without ophthalmic pathology
Subjects with Retinal Vascular PathologyColor Fundus PhotographyColor Fundus Photography, Optical Coherence Tomography, and OCT Angiography scans as per protocol in subjects with retinal vascular ophthalmic pathology
Subjects with Normal EyesColor Fundus PhotographyColor Fundus Photography, Optical Coherence Tomography, and OCT Angiography scans as per protocol in subjects without ophthalmic pathology
Subjects with Retinal Vascular PathologyOptical Coherence TomographyColor Fundus Photography, Optical Coherence Tomography, and OCT Angiography scans as per protocol in subjects with retinal vascular ophthalmic pathology
Subjects with Retinal Vascular PathologyOCT AngiographyColor Fundus Photography, Optical Coherence Tomography, and OCT Angiography scans as per protocol in subjects with retinal vascular ophthalmic pathology
Primary Outcome Measures
NameTimeMethod
OCTA image qualityday 1

Image quality grading results of study selected images

Visualization of key anatomical vascular structures on OCTAday 1

Grading of visibility of key anatomical vascular structures of study selected images

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

State University of New York College of Optometry (SUNY)

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath